Literature DB >> 34165072

Multimodal sleep, an innovation for treating chronic insomnia: case report and literature review.

Jian-Feng Zhang1,2, John P Williams3, Qian-Nan Zhao1, Hui Liu1, Wan-Rui Shi4, Yong Wang1, Qi-Wu Fang1, Jian-Xiong An1,2,5.   

Abstract

The authors present the clinical case of a 67-year-old man with severe insomnia for 5 years with an exacerbation about 1 year before consultation. He did not have enough concentration and energy for his daily work and developed depression and anxiety because of his excessive daytime sleepiness. During his insomniac state, a drug treatment provided partial relief, but the effects were not long-lasting. Consequently, the drug dosage increased, and major side effects gradually manifested. We decided to use a completely new therapeutic strategy for this patient to improve his sleep quality and mental symptoms. In time, the patient could stop oral medications and that is multimodal sleep. After the end of multimodal sleep, the patient typically experiences improvement in sleep quality and architecture. Additionally, the dosage of hypnotics used before multimodal sleep is discontinued without severe withdrawal symptoms. CITATION: Zhang J-F, Williams JP, Zhao Q-N, et al. Multimodal sleep, an innovation for treating chronic insomnia: case report and literature review. J Clin Sleep Med. 2021;17(8):1737-1742.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  chronic insomnia; dexmedetomidine; multimodal sleep; patient-controlled sleep

Mesh:

Year:  2021        PMID: 34165072      PMCID: PMC8656903          DOI: 10.5664/jcsm.9310

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.324


  20 in total

1.  Insomnia symptoms and risk for unintentional fatal injuries--the HUNT Study.

Authors:  Lars Erik Laugsand; Linn B Strand; Lars J Vatten; Imre Janszky; Johan Håkon Bjørngaard
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

2.  Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood.

Authors:  Wallace C Duncan; Elizabeth D Ballard; Carlos A Zarate
Journal:  Handb Exp Pharmacol       Date:  2019

3.  Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss.

Authors:  James K Walsh; Janine M Hall-Porter; Kara S Griffin; Ehren R Dodson; Elizabeth H Forst; Denise T Curry; Rhody D Eisenstein; Paula K Schweitzer
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

4.  Alpha-2 adrenoceptor activity affects propofol-induced sleep time.

Authors:  Tetsuya Kushikata; Kazuyoshi Hirota; Hitoshi Yoshida; Takeshi Kubota; Hironori Ishihara; Akitomo Matsuki
Journal:  Anesth Analg       Date:  2002-05       Impact factor: 5.108

5.  Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.

Authors:  Charles M Morin; Annie Vallières; Bernard Guay; Hans Ivers; Josée Savard; Chantal Mérette; Célyne Bastien; Lucie Baillargeon
Journal:  JAMA       Date:  2009-05-20       Impact factor: 56.272

6.  Dexmedetomidine promotes biomimetic non-rapid eye movement stage 3 sleep in humans: A pilot study.

Authors:  Oluwaseun Akeju; Lauren E Hobbs; Lei Gao; Sara M Burns; Kara J Pavone; George S Plummer; Elisa C Walsh; Tim T Houle; Seong-Eun Kim; Matt T Bianchi; Jeffrey M Ellenbogen; Emery N Brown
Journal:  Clin Neurophysiol       Date:  2017-10-20       Impact factor: 3.708

7.  Addiction and reward-related genes show altered expression in the postpartum nucleus accumbens.

Authors:  Changjiu Zhao; Brian Earl Eisinger; Terri M Driessen; Stephen C Gammie
Journal:  Front Behav Neurosci       Date:  2014-11-05       Impact factor: 3.558

8.  Spatiotemporal Dynamics of Dexmedetomidine-Induced Electroencephalogram Oscillations.

Authors:  Oluwaseun Akeju; Seong-Eun Kim; Rafael Vazquez; James Rhee; Kara J Pavone; Lauren E Hobbs; Patrick L Purdon; Emery N Brown
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

Review 9.  The roles of sodium channels in nociception: Implications for mechanisms of pain.

Authors:  Theodore R Cummins; Patrick L Sheets; Stephen G Waxman
Journal:  Pain       Date:  2007-09-04       Impact factor: 7.926

Review 10.  Multimodal General Anesthesia: Theory and Practice.

Authors:  Emery N Brown; Kara J Pavone; Marusa Naranjo
Journal:  Anesth Analg       Date:  2018-11       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.